Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.100 | None | 0.810 | 1 | 0 | 1997 | 2018 | ||||||||
|
atypical chemokine receptor 1 (Duffy blood group) | 0.608 | 0.731 | 2.1E-04 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
activin A receptor type 1 | 0.535 | 0.731 | 0.33 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
disease | 0.150 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
ADAM metallopeptidase domain 33 | 0.636 | 0.423 | 2.1E-15 |
|
disease | 0.100 | None | 0.935 | 8 | 0 | 2002 | 2019 | ||||||||
|
ADAM metallopeptidase domain 8 | 0.590 | 0.731 | 2.2E-14 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2007 | 2014 | ||||||||
|
alcohol dehydrogenase 5 (class III), chi polypeptide | 0.604 | 0.731 | 2.5E-11 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2008 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.500 | None | 0.956 | 10 | 0 | 1993 | 2020 | ||||||||
|
arachidonate 15-lipoxygenase | 0.502 | 0.846 | 1.1E-23 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.500 | None | 0.950 | 4 | 0 | 1997 | 2020 | ||||||||
|
arachidonate 5-lipoxygenase activating protein | 0.612 | 0.731 | 7.1E-02 |
|
disease | 0.100 | None | 0.800 | 1 | 0 | 1998 | 2012 | ||||||||
|
angiopoietin 1 | 0.446 | 0.808 | 0.95 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
annexin A2 | 0.453 | 0.808 | 9.8E-05 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2013 | ||||||||
|
amphiregulin | 0.487 | 0.769 | 0.35 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
arginase 1 | 0.476 | 0.846 | 3.6E-04 |
|
disease | 0.400 | None | 0.909 | 1 | 0 | 2003 | 2018 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
bradykinin receptor B1 | 0.619 | 0.731 | 4.7E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.100 | None | 0.958 | 2 | 0 | 2003 | 2019 | ||||||||
|
bone morphogenetic protein receptor type 1B | 0.573 | 0.615 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
bone morphogenetic protein receptor type 2 | 0.538 | 0.654 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
disease | 0.050 | None | 1.000 | 2 | 0 | 2000 | 2008 | ||||||||
|
complement C3a receptor 1 | 0.601 | 0.731 | 3.3E-09 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 |